Skip to main content

WARN Act Layoffs in New Jersey

Tracking mass layoff and plant closure notices filed under the WARN Act in New Jersey, updated daily. Explore the interactive data →

135
Notices in 2026
14,761
Workers Affected
Verizon
Biggest Filing (1,319)
Manufacturing
Top Industry
Parsippany
Most Affected City

Data Insights

Industry Breakdown

Workers affected by industry sector

6-Month Trend

Monthly WARN notices and workers affected

Latest WARN Notices in New Jersey

WARN Act layoff notices
CompanyCityEmployeesNotice DateType
Novartis Group EastHanover3
Acme MarketsEdgewater115
Acme MarketsEdgewater3
BarclaysWhippany64
BarclaysWhippany3
Amicus TherapeuticsPrinceton58
Amicus TherapeuticsPrinceton3
JPMorgan ChaseJersey City51
Embassy Suites by HiltonParsippany54
Spirit AirlinesNewark201
Spirit AirlinesNewark3
VerizonBasking Ridge121
VerizonBasking Ridge3
DoubleTree by HiltonSomerset90
DoubleTree by HiltonSomerset3
Danone North AmericaBridgeton114
AccupacLakewood260
Worldwide Flight ServicesElizabeth100
Fulton BankParsippany95
Fulton BankParsippany3
Labor Market Snapshot — New Jersey (DOL/BLS)
4.8%
Unemployment
(April 2026)
7,882
Initial Claims
(2026-05-09 wk)
2.54%
Insured Unemp. Rate
(2026-05-09 wk)

In-Depth Analysis: Layoffs in New Jersey

# New Jersey's Layoff Crisis: Scale, Concentration, and the Collision Between Structural Decline and Foreign Labor Policy

Executive Summary: A State Under Sustained Workforce Pressure

New Jersey has experienced a severe and protracted layoff crisis, with 2,384 WARN (Worker Adjustment and Retraining Notification) notices affecting 385,019 workers since 2004. This scale of disruption—representing roughly 8.6% of the state's current nonfarm payroll of 3.85 million—signals deep structural instability across multiple economic sectors. What distinguishes New Jersey's layoff pattern is not merely its magnitude but its persistence: after a particularly acute spike in 2020 (215 notices, 72,562 workers), the state has failed to return to pre-pandemic baseline levels. The 2025–2026 period shows 271 notices and 34,240 workers affected, continuing a trend that suggests the state is managing chronic, sector-wide workforce reductions rather than recovering from a discrete economic shock.

The current labor market context, while superficially stable, masks underlying fragility. New Jersey's unemployment rate stands at 4.9% as of March 2026, above the national rate of 4.3%, and the state's insured unemployment rate of 2.54% is rising on a four-week trend, up 4.5% compared to the prior period. Initial jobless claims in New Jersey hit 7,882 in the week ending May 9, 2026—down 52.8% year-over-year but up 4.5% in the most recent four-week window. This divergence between strong headline year-over-year improvement and deteriorating near-term trends suggests that the labor market is not genuinely healing but rather normalizing after an exceptionally weak prior year, while still experiencing ongoing separation pressures.

The Dual Crisis: Manufacturing Collapse and Retail Disintegration

Two industries dominate New Jersey's layoff landscape and tell distinct but equally consequential stories of structural economic transformation. Manufacturing has filed 680 WARN notices affecting 79,235 workers—representing 28.5% of all notices but only 20.6% of affected workers, indicating smaller average plant closures. Retail has generated 407 notices affecting 51,642 workers (17.1% of notices, 13.4% of workers), with substantially larger average layoff sizes reflecting the collapse of regional distribution networks and store rationalization.

The manufacturing decline reflects automation, offshoring, and the exhaustion of New Jersey's historical competitive advantages in chemical production, pharmaceuticals, and precision manufacturing. Novartis Pharmaceuticals leads all employers with 31 WARN notices displacing 3,571 workers, while Bristol Myers Squibb (counted as separate entities in the data) filed 24 notices collectively affecting 4,741 workers. These are not failing companies; they are highly profitable pharmaceutical manufacturers systematically consolidating operations, eliminating redundant facilities after mergers and acquisitions, and relocating research and manufacturing to lower-cost jurisdictions. The 2020 COVID-19 surge created temporary demand for pharmaceutical manufacturing, masking underlying consolidation pressures. As demand normalized, these companies accelerated restructuring, using health crisis recovery as cover for permanent headcount reductions.

Retail layoffs represent a different mechanism: demand destruction from e-commerce penetration and the rationalization of store formats. Walmart has filed 11 WARN notices affecting 2,613 workers, while Kmart (before its complete dissolution) filed 8 notices affecting 655 workers, and Bed Bath & Beyond filed 6 notices affecting 1,565 workers. The scale of Bed Bath & Beyond's displacement relative to its notice count—averaging 260 workers per notice compared to Walmart's 238—reflects the company's terminal contraction before bankruptcy. Retail employment in New Jersey has experienced cumulative destruction, with 407 notices reflecting not opportunistic restructuring but the permanent shrinkage of an industry that once provided stable middle-class employment to hundreds of thousands of state residents.

The Accommodation and Food Services sector presents a third pattern: 154 notices affecting 33,853 workers, with higher average displacement (220 workers per notice) reflecting pandemic-driven permanent closures and consolidation in hospitality. Airlines, food service contractors, and hotel operators all filed substantial notices during 2020–2021, and while the raw numbers have declined, the jobs have not returned proportionally to pre-pandemic levels.

Together, these three sectors (manufacturing, retail, hospitality) account for 1,241 notices affecting 164,730 workers—64.8% of all WARN filings and 42.8% of affected workers. This concentration indicates that New Jersey's economic base has undergone sequential destabilization: first manufacturing (1980s–2000s), then retail (2010s–present), then hospitality (2020–present). The state's economy is losing its traditional employment anchors without equivalent replacement in higher-value sectors.

Geographic Concentration: Newark's Outsized Burden

New Jersey's layoffs are geographically concentrated in ways that exacerbate regional inequality and overwhelm local adjustment capacity. Newark, the state's largest city, accounts for 159 WARN notices affecting 58,158 workers—24.5% of all workers affected statewide despite representing roughly 5% of state population. This concentration reflects Newark's role as a regional transportation and logistics hub (United Airlines alone has filed 5 notices affecting 12,572 workers, largely centered in Newark), a pharmaceutical manufacturing cluster, and a retail distribution center network.

The scale of Newark's displacement is staggering relative to its existing employment base. Newark's workforce numbers approximately 120,000–130,000 workers. A loss of 58,158 jobs (and these are gross losses, not accounting for hiring) represents disruption affecting roughly 45% of the city's workforce. The local adjustment capacity—job training programs, community colleges, workforce development agencies—cannot absorb disruptions of this magnitude. Workers displaced from United Airlines operations (average salary likely $55,000–$75,000 for ground operations and customer service) must either commute to distant regions, accept substantial wage cuts, or leave the state entirely.

Jersey City (100 notices, 15,684 workers), Atlantic City (39 notices, 28,461 workers), and Parsippany (66 notices, 6,998 workers) together account for an additional 50,843 workers. Atlantic City's concentration reflects the near-complete hollowing of the casino gambling industry—the 28,461 figure suggests that nearly every major casino has filed WARN notices, eliminating the hospitality and gaming employment that once formed the city's economic core.

The suburban pharmaceutical belt—East Hanover (44 notices, 4,799 workers), Princeton (35 notices, 2,670 workers), and Bridgewater (31 notices, 4,404 workers)—shows concentrated pharmaceutical manufacturing job losses, reflecting the industry's consolidation and automation. These are relatively affluent, college-educated communities with better economic resilience, but even here the displacement is substantial.

The Pharmaceutical Paradox: Consolidation and Concentration Risk

New Jersey has positioned itself as the pharmaceutical capital of the United States, with a disproportionate share of major drug manufacturers' operations. This concentration creates both economic dynamism and extreme vulnerability. The top five pharmaceutical and life sciences employers in the state have each filed multiple WARN notices, with Novartis, Bristol Myers Squibb, Merck, Johnson & Johnson (through subsidiaries), and CVS Health collectively accounting for substantial displacement.

What distinguishes this pattern is that these are not failing companies; they are industry leaders with strong balance sheets. Bristol Myers Squibb's 24 combined notices reflect the company's acquisition of Celgene in 2019 and subsequent facility consolidation, not financial distress. Novartis's 31 notices represent ongoing restructuring as the company reallocates research and manufacturing globally, closing redundant New Jersey facilities while maintaining some operations in the state. This pattern—profitable companies eliminating jobs—is fundamentally different from traditional layoffs driven by demand destruction or insolvency. These are structural reductions reflecting both automation (pharmaceutical manufacturing is increasingly automated, reducing labor intensity) and global supply chain optimization (locating research in lower-cost regions, consolidating manufacturing).

The pharmaceutical sector's dominance in New Jersey's economy creates a second problem: policy capture. As the state's largest private sector employer group, pharmaceutical companies exercise substantial influence over state economic policy, workforce development spending, and tax policy. This political economy makes it difficult for the state to implement aggressive retraining, wage insurance, or relocation assistance for displaced pharmaceutical workers. Instead, the state pursues "talent attraction" policies designed to lure new pharmaceutical operations, which generates incremental jobs without fully replacing losses.

Historical Trajectory: The 2020 Collapse and Incomplete Recovery

New Jersey's WARN notice pattern reveals a labor market under sustained stress with periodic acute crises. The period 2004–2007 shows baseline activity of approximately 90–97 notices annually, affecting roughly 13,000–14,800 workers per year. The 2008–2009 financial crisis elevated this to 139 notices (2008) and 127 notices (2009), affecting 22,412 and 16,248 workers respectively—representing roughly 50% increases over baseline.

Critically, the state never fully returned to pre-2008 baseline after the recovery. From 2010–2019, the average was approximately 100 notices annually, suggesting that New Jersey's labor market normalized at a structurally higher layoff rate than the pre-crisis period. This indicates that the financial crisis didn't cause a temporary shock but rather a permanent elevation in workforce separation rates, likely driven by accelerated retail contraction, pharmaceutical consolidation, and ongoing manufacturing decline.

The 2020 pandemic shock was catastrophic: 215 WARN notices affecting 72,562 workers, representing a 175% increase in notices and a 475% increase in affected workers compared to 2019. This reflects simultaneous collapse across hospitality, retail, transportation, and food services. The 2021 recovery (49 notices, 10,583 workers) represented only a 70% reduction in notices from the 2020 peak, suggesting that while some layoffs reversed, many permanent closures never reopened.

The subsequent pattern—2022 (43 notices, 4,929 workers), 2023 (126 notices, 16,081 workers), 2024 (121 notices, 16,337 workers), 2025 (136 notices, 17,903 workers), and 2026 YTD (135 notices, 14,761 workers)—reveals a state trapped in a new, higher-baseline equilibrium. The average for 2023–2026 is approximately 129 notices annually, affecting 16,270 workers per year. This is 29% higher than the pre-pandemic baseline (2004–2019 average of 100 notices) and 80% higher than the pre-2008 baseline. The state has not recovered; it has normalized at a new, elevated level of workforce turbulence.

H-1B Foreign Labor and Simultaneous Displacement: The Policy Contradiction

New Jersey presents a remarkable contradiction: the state is simultaneously experiencing sustained layoffs across multiple sectors while serving as a major destination for H-1B visa sponsorship. The state has 245,585 certified H-1B/LCA petitions from 18,941 unique employers, with an average salary of $96,911. The top occupations are computer-intensive: Computer Programmers (26,309 petitions, average $66,577), Computer Systems Analysts (22,241 petitions, average $78,224), and Software Developers (20,265 petitions combined, averaging $88,492–$310,473 depending on specification).

The contrast becomes acute when examining specific employers. Infosys Technologies, Tata Consultancy Services, Larsen & Toubro Infotech, IBM India Private Limited, and Cognizant collectively account for 26,241 H-1B petitions—representing Indian IT outsourcing firms that bring foreign workers to the United States to perform software development, systems analysis, and IT support work. These same firms and their clients have been major WARN filers throughout the period studied.

The policy implication is troubling: New Jersey's economy is shedding mid-skilled and skilled jobs across manufacturing, pharmaceuticals, IT, and retail while simultaneously importing foreign workers to perform technical roles. This is consistent with a broader pattern of occupational displacement: legacy jobs in manufacturing, customer service, and distribution are being eliminated through automation and offshoring, while new jobs in technology require either highly specialized expertise (commanding $150,000+) or rely on H-1B workers compensated below market rates for comparable American workers. The median H-1B salary of $96,911 is substantially below the U.S. average for computer programmers ($105,000+), suggesting wage suppression effects.

For New Jersey workers, this creates a bifurcated labor market: high-skill, high-wage technology positions are increasingly filled by H-1B workers, while mid-skill positions (which once provided stable manufacturing and clerical work) have been eliminated. Workers displaced from Bristol Myers Squibb pharmaceutical operations or Walmart distribution centers cannot retrain into H-1B-eligible positions without substantial additional education and carry the risk that even after retraining, salary competition from foreign workers will suppress wages.

Bankruptcy, Insolvency, and Firm Distress Signals

The 370 Chapter 11 bankruptcy filings matched to WARN companies in the last 90 days indicate that some layoffs reflect terminal firm distress rather than strategic restructuring. Recent WARN-matched bankruptcies include Spirit Airlines (6 WARN notices, 412 workers), which filed for Chapter 11 protection despite previous restructuring, and Corizon Health, a healthcare services provider that failed after sustained workforce reductions. The presence of bankruptcy signals suggests that the WARN data is capturing both strategic restructuring by healthy firms and genuine economic distress.

However, the data also suggests that the largest layoff employers are not the firms in bankruptcy but rather highly profitable companies executing consolidation strategies. Bristol Myers Squibb, Novartis, Walmart, and JPMorgan Chase are all financially robust institutions using layoffs as optimization tools rather than desperate measures. This distinction matters for policy design: if layoffs are driven primarily by firm distress, retraining and wage insurance might be sufficient. If driven by profitable companies extracting value through headcount reduction, the policy response must address incentive structures and potentially restrict layoff practices.

Implications and Critical Considerations for Workers and Policymakers

New Jersey faces a labor market in which structural employment loss has become normalized, with 385,019 cumulative displacements since 2004 representing a permanent loss of productive capacity within the state. The 2025–2026 trajectory shows no indication of deceleration. Current unemployment and underemployment rates, while appearing acceptable at headline level, reflect not genuine labor market health but rather a workforce adapting to chronic job loss through exits from the labor force, underemployment, and outmigration.

The pharmaceutical sector's dominance creates particular policy brittleness: a single major pharmaceutical company's strategic decision to consolidate or relocate operations can affect tens of thousands of workers, with local effects in cities like Newark and Parsippany being catastrophic. The state's economic development strategy—attempting to attract new pharmaceutical operations—is fundamentally reactive and inadequate to the scale of ongoing losses.

For workers, the implications are severe. Displaced workers from manufacturing and retail face retraining into sectors where H-1B competition suppresses wages and where new job creation is limited. Younger workers should expect lower lifetime earnings and less stable employment than their parents' generation. Workers in pharmaceutical manufacturing and IT support roles face a narrowing employment window and potential displacement through automation or offshoring.

For policymakers, the data suggests that incremental adjustment policies—job training, community college funding, wage insurance—are insufficient to address a structural crisis of this magnitude. The state requires direct intervention in firm labor practices, potentially through legal restrictions on mass layoffs by profitable companies, labor standards enforcement, and genuine sectoral diversification strategy rather than continued attraction of pharmaceutical operations that are themselves sources of ongoing displacement.

Latest New Jersey Layoff Reports